Wang Fen-Fen, Li Rong, Liao Dan, Liu Chao-Qun, Yang Xiao-Li
Department of Endocrinology and Metabolism, the First Affiliated Hospital of Xi'an Medical University, Xi'an 710077, Shaanxi Province, China.
Department of Ophthalmology, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan Province, China.
Int J Ophthalmol. 2025 Jun 18;18(6):978-985. doi: 10.18240/ijo.2025.06.02. eCollection 2025.
To investigate the protective role of ghrelin against diabetic retinopathy (DR), focusing on its anti-ferroptotic mechanism in high glucose-induced retinal endothelial injury.
First, small interfering RNA (siRNA)-mediated interference was conducted to knockdown nuclear factor erythroid 2-related factor 2 (Nrf2). Using reverse transcription-polymerase chain reaction (RT-PCR), the expression level of Nrf2 was determined from human retinal microvascular endothelial cells (HRMECs) transfected with either si-NC or si-Nrf2. After that, cells were treated with 10 nmol/L ghrelin and then cultured in a high glucose (30 mmol/L) environment. EdU assay was utilized to assess cell proliferation, while transmission electron microscopy was employed to observe mitochondrial morphology. Flow cytometry was used to measure the level of intracellular reactive oxygen species (ROS), and biochemical assays were conducted to detect malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), and ferrous iron (Fe). Western blotting was used to identify the presence of ferroptosis-related proteins such as glutathione peroxidase 4 (GPX4), solute carrier family 7 member 11 (SLC7A11), Nrf2, and haem oxygenase-1 (HO-1).
Under a high glucose environment, ghrelin could significantly promote the proliferation of HRMECs and mitochondrial status, remarkably decrease the levels of intracellular ROS and MDA, and up-regulate the level of GSH and SOD. Besides, ghrelin greatly reduced Fe level in the cells while increased protein levels of GPX4 and SLC7A11. Subsequently, we found that high glucose induced inactivation of Nrf2/HO-1 axis and the protein expression profile were significantly promoted by ghrelin. Moreover, silencing of Nrf2 by siRNA delivery markedly diminished the changes induced by ghrelin in high glucose-induced HRMECs, shown as reduced cell proliferation and increased mitochondrial malformation, up-regulated ROS, MDA, Fe, GPX4 and SLC7A11, as well as down-regulated GSH, SOD, Nrf2 and HO-1.
Ghrelin attenuates high glucose-induced injury of retinal endothelial cells inhibiting ferroptosis, and activation of Nrf2/HO-1 pathway may be one of the mechanisms involved in this effect of ghrelin.
研究胃饥饿素对糖尿病视网膜病变(DR)的保护作用,重点关注其在高糖诱导的视网膜内皮细胞损伤中的抗铁死亡机制。
首先,进行小干扰RNA(siRNA)介导的干扰以敲低核因子红细胞2相关因子2(Nrf2)。使用逆转录-聚合酶链反应(RT-PCR)从转染了si-NC或si-Nrf2的人视网膜微血管内皮细胞(HRMECs)中测定Nrf2的表达水平。之后,用10 nmol/L胃饥饿素处理细胞,然后在高糖(30 mmol/L)环境中培养。采用EdU检测法评估细胞增殖,同时用透射电子显微镜观察线粒体形态。用流式细胞术测量细胞内活性氧(ROS)水平,并进行生化检测以检测丙二醛(MDA)、谷胱甘肽(GSH)、超氧化物歧化酶(SOD)和亚铁(Fe)。用蛋白质印迹法鉴定铁死亡相关蛋白如谷胱甘肽过氧化物酶4(GPX4)、溶质载体家族7成员11(SLC7A11)、Nrf2和血红素加氧酶-1(HO-1)的存在情况。
在高糖环境下,胃饥饿素可显著促进HRMECs的增殖和线粒体状态,显著降低细胞内ROS和MDA水平,并上调GSH和SOD水平。此外,胃饥饿素可大幅降低细胞内Fe水平,同时增加GPX4和SLC7A11的蛋白水平。随后,我们发现高糖诱导Nrf2/HO-1轴失活,而胃饥饿素可显著促进其蛋白表达谱。此外,通过siRNA传递沉默Nrf2可显著减弱胃饥饿素在高糖诱导的HRMECs中所诱导的变化,表现为细胞增殖减少、线粒体畸形增加、ROS、MDA、Fe、GPX4和SLC7A11上调,以及GSH、SOD、Nrf2和HO-1下调。
胃饥饿素通过抑制铁死亡减轻高糖诱导的视网膜内皮细胞损伤,Nrf2/HO-1通路的激活可能是胃饥饿素发挥这一作用的机制之一。